What this means: Proqr Therapeutics (PRQR) gets an Overall Rank of 63, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a …

ProQR Therapeutics N.V Stock Price Forecast, "PRQR" Predictons for2024

ProQR Therapeutics N.V. analyst ratings, historical stock prices, earnings estimates & actuals. PRQR updated stock price target summary. View live PROQR THERAPEUTICS N V chart to track its stock's price action. Find market predictions, PRQR financials and market news.

The average price target represents a 485.28% increase from the last price of $5.98. 2021-04-12 · According to 6 analysts, the average rating for PRQR stock is "Strong Buy." The 12-month stock price forecast is 26.06, which is an increase of 335.79% from the latest price. 2020-08-17 · PRQR: Get the latest ProQR Therapeutics B.V. stock price and detailed information including PRQR news, historical charts and realtime prices. What this means: Proqr Therapeutics (PRQR) gets an Overall Rank of 63, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. ProQR Therapeutics N.V Stock Price Forecast, "PRQR" Predictons for2024 Proqr Therapeutics stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. 2021-03-26 · ProQR Therapeutics N.V. (NASDAQ: PRQR) is 119.52% higher on its value in year-to-date trading and has touched a low of $3.40 and a high of $7.54 in the current 52-week trading range.

Proqr Therapeutics Forecast Models Proqr Therapeutics time-series forecasting models is one of many Proqr Therapeutics' stock analysis techniquest aimed to predict future share value based on previously observed values.

Proqr Therapeutics stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.

View ProQR Therapeutics N.V price, streaming chart and supplemental info. Read market forecasts, PRQR financials, economic background and market news ProQR (PRQR) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well. ProQR Therapeutics NV is a Dutch biotechnology company based in Leiden, the Netherlands. ProQR was founded in 2012 by CEO Daniel de Boer and co-founders Henri Termeer, Dinko Valerio and … This report will help you analyze the stock performance of ProQR Therapeutics NV (PRQR) in the last 6 months.

ProQR Therapeutics N.V. - Ordinary Shares (PRQR): Price and Financial Metrics We have 9 different ratings for every stock to help you appreciate its future

Last updated 2020/10/28 00:42 2021-04-15 ProQR Therapeutics NV Stock Dividend Yield & Dates Add to Watchlist. Overview Forecast Earnings Dividend.

PRQR's price/sales ratio is 30.33; that's higher than the P/S ratio of 92.29% of US stocks. With a year-over-year growth in debt of 165.83%, ProQR Therapeutics NV's debt growth rate surpasses 92.83% of about US stocks. Find the latest ProQR Therapeutics N.V. (PRQR) stock quote, history, news and other vital information to help you with your stock trading and investing. 2021-04-14 2021-04-14 ProQR Therapeutics NV is a biopharmaceutical company, which engages in the discovery and development of RNA therapies for the treatment of severe genetic rare diseases such as Leber congenital amaurosis 10, Usher syndrome and retinitis pigmentosa. Its product pipeline include Sepofarsen, QR-421a, QR-1123, and QR-504a.
Investeringsselskabet luxor a s

2021-04-12 1852 rows 2020-06-07 ProQR Therapeutics N.V Stock Price Forecast, "PRQR" Predictons for2024 Proqr Therapeutics stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. What this means: Proqr Therapeutics (PRQR) gets an Overall Rank of 63, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a … 2021-03-26 2021-04-14 PRQR Stock Summary. PRQR's price/sales ratio is 30.33; that's higher than the P/S ratio of 92.29% of US stocks.
Sofia bennet

eva von wowern
dagens skola ska
adam sevani now
lämplighetsintyg körkort pris
låneskydd handelsbanken arbetslöshet
tics vuxna

Shares of ProQR Therapeutics are up 36% in morning trading after Citi upgraded its price target from $33 to $44. Seeking Alpha; Mar 25, 2021 10:19.

How much is ProQR … At September 30, 2019, ProQR had cash and cash equivalents of €74.8 million. On October 18, 2019, the Company raised net proceeds of roughly €49.3 million from a public offering. View the latest PRQR stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of ProQR Therapeutics NV. ProQR Therapeutics market cap history and chart from 2015 to 2020. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. View ProQR Therapeutics N.V price, streaming chart and supplemental info.

Historical daily share price chart and data for Spero Therapeutics since 2021 adjusted for splits. The latest closing stock price for Spero Therapeutics as of April 14, 2021 is 13.18. ProQR Therapeutics (PRQR), Netherlands, $0.300B,

Read full article. The EIA has raised its forecast of non-OPEC supply in the second half of 2021 by almost 2021-04-15 · Get the latest ProQR Therapeutics N.V. PRQR detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Proqr Therapeutics N.v. - PRQR - Stock Price Today - Zacks PRQR is down today, 2021-04-14 · ProQR Therapeutics N.V. Ordinary Shares. (PRQR) Nasdaq Listed. Nasdaq 100. $6.52. +0.35 (+5.67%) CLOSED AT 4:00 PM ET ON Apr 08, 2021.

But such an analysis will help you do a quick relative check of PRQR against peers or industry benchmarks. ProQR Therapeutics NASDAQ Updated Mar 25, 2021 11:59 PM. PRQR 9.22 3.54 (62.32%).